Transcat (NASDAQ:TRNS) Hits New 1-Year High at $116.19

Shares of Transcat, Inc. (NASDAQ:TRNS) reached a new 52-week high during trading on Tuesday . The company traded as high as $116.19 and last traded at $114.98, with a volume of 52441 shares traded. The stock had previously closed at $111.35.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on TRNS. Oppenheimer restated an “outperform” rating and set a $125.00 target price (up previously from $120.00) on shares of Transcat in a research note on Thursday, April 18th. TheStreet raised Transcat from a “c+” rating to a “b” rating in a research report on Wednesday, January 31st. Finally, HC Wainwright reissued a “buy” rating and set a $124.00 price target on shares of Transcat in a report on Tuesday, April 16th.

Transcat Stock Down 1.3 %

The company has a market capitalization of $969.89 million, a P/E ratio of 84.49 and a beta of 0.59. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. The stock has a 50 day moving average price of $108.71 and a 200 day moving average price of $102.50.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. The firm had revenue of $65.17 million during the quarter, compared to analysts’ expectations of $63.36 million. Transcat had a net margin of 4.16% and a return on equity of 9.32%. On average, research analysts anticipate that Transcat, Inc. will post 1.34 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of the stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $111.30, for a total transaction of $556,500.00. Following the completion of the sale, the chief executive officer now directly owns 108,478 shares in the company, valued at approximately $12,073,601.40. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $111.30, for a total value of $556,500.00. Following the transaction, the chief executive officer now directly owns 108,478 shares of the company’s stock, valued at $12,073,601.40. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Charles P. Hadeed sold 700 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $113.00, for a total transaction of $79,100.00. Following the sale, the director now directly owns 22,678 shares of the company’s stock, valued at approximately $2,562,614. The disclosure for this sale can be found here. Insiders sold 8,073 shares of company stock valued at $900,023 over the last quarter. Insiders own 4.20% of the company’s stock.

Hedge Funds Weigh In On Transcat

Several institutional investors have recently made changes to their positions in TRNS. Rice Hall James & Associates LLC increased its position in Transcat by 0.4% in the 1st quarter. Rice Hall James & Associates LLC now owns 27,472 shares of the scientific and technical instruments company’s stock valued at $3,061,000 after buying an additional 96 shares in the last quarter. Wasatch Advisors LP grew its stake in Transcat by 7.9% in the first quarter. Wasatch Advisors LP now owns 756,220 shares of the scientific and technical instruments company’s stock valued at $84,266,000 after acquiring an additional 55,121 shares during the period. Diversified Trust Co increased its holdings in shares of Transcat by 23.6% during the first quarter. Diversified Trust Co now owns 3,010 shares of the scientific and technical instruments company’s stock valued at $335,000 after acquiring an additional 575 shares in the last quarter. Annex Advisory Services LLC raised its position in shares of Transcat by 6.1% during the first quarter. Annex Advisory Services LLC now owns 9,155 shares of the scientific and technical instruments company’s stock worth $1,020,000 after purchasing an additional 526 shares during the period. Finally, Broadcrest Asset Management LLC lifted its holdings in shares of Transcat by 17.6% in the 4th quarter. Broadcrest Asset Management LLC now owns 400,000 shares of the scientific and technical instruments company’s stock worth $43,732,000 after purchasing an additional 60,000 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.